发明名称 |
Antibiotic compositions and related screening methods |
摘要 |
Moenomycin inhibits bacterial growth by clocking the transglycosylase activity of class A penicillin-binding proteins (PBPs), which are key enzymes in bacterial cell wall synthesis. The binding affinities of moenomycin A with various truncated PBPs were compared showing that the transmembrane domain is important for moenomycin binding. Full-length class-A PBPs from 16 bacterial species were produced, and their binding activities showed a correlation with the antimicrobial activity of moenomycin against Enterococcus faecalis and Staphylococcus aureus. Moreover, a fluorescence anisotropy-based high-throughput assay was developed and used successfully for identification of transglycosylase inhibitors. |
申请公布号 |
US8916540(B2) |
申请公布日期 |
2014.12.23 |
申请号 |
US200912354717 |
申请日期 |
2009.01.15 |
申请人 |
Academia Sinica |
发明人 |
Wong Chi-Huey;Cheng Ting-Jen;Ma Che Alex;Cheng Wei-Chieh |
分类号 |
C07K14/195;C07K14/26;C07K14/315;C07K14/25;C07K14/235;C07K14/32;C07K14/31;C07K14/21;C07K14/33;C07K14/255;C07K14/22;C07K14/265;G01N33/573;A61K31/19;A61K31/715;A61K31/427;A61K31/365 |
主分类号 |
C07K14/195 |
代理机构 |
Eckman Basu LLP |
代理人 |
Eckman Basu LLP |
主权项 |
1. A method for high throughput screening (HTS) of antibacterial agents, the method comprising:
providing a candidate agent for screening; providing a class A penicillin-binding protein, or fragment thereof (PBP), from a bacterial species, comprising at least a transmembrane (TM) domain and a transglycosylase (TG) domain; determining a first binding affinity of the candidate agent to the at least transmembrane (TM) domain and transglycosylase (TG) domain-containing fragment of the class A penicillin-binding protein; comparing the first binding affinity to a second binding affinity of the candidate agent to a class A penicillin-binding protein fragment that lacks the TM domain; identifying a candidate agent as a putative transglycosylase inhibitor of the bacterial species as the antibacterial agent, wherein the candidate agent exhibits a higher first binding affinity to the transmembrane (TM) domain-containing class A penicillin-binding protein, or fragment thereof, as compared to the second binding affinity to the PBP fragment that lacks the TM domain; and confirming the transglycosylase inhibitor activity of the putative transglycolase inhibitor by testing for an ability to inhibit growth of the same bacterial species whose PBP transmembrane domain-containing fragment it binds with higher affinity, wherein the binding affinity between the candidate agent and the transmembrane (TM) domain of the class A penicillin-binding protein is determined by anisotropy measurement assay. |
地址 |
Taipei TW |